Blood Pressure Control After SPRINT-Back to Reality.
Published in JAMA cardiology
Published in JAMA cardiology
Published in JAMA cardiology
Published in JAMA cardiology
Published in JAMA cardiology
The Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive blood pressure control reduced cardiovascular morbidity and mortality. However, the legacy effect of intensive treatment is unknown. To evaluate the long-term effects of randomization to intensive treatment with the incidence of cardiovascular and all-cause mortality appr...
Published in JAMA cardiology
This Viewpoint discusses the concerns about using mineral oil as a placebo.
Published in JAMA cardiology
Oral anticoagulation (OAC) is underprescribed in underrepresented racial and ethnic group individuals with atrial fibrillation (AF). Little is known of how differential OAC prescribing relates to inequities in AF outcomes. To compare OAC use at discharge and AF-related outcomes by race and ethnicity in the Get With The Guidelines-Atrial Fibrillatio...
Published in JAMA cardiology
This Viewpoint discusses the findings of the Reduction of Cardiovascular Events With Icosapent Ethyl Intervention Trial regarding the use of icosapent ethyl in moderate- to high-risk patients with fasting triglyceride levels greater than 135 mg/dL.
Published in JAMA cardiology
Internal medicine residents' professional development preferences were discordant with their perceptions of cardiology in a survey circulated a decade ago; no contemporary data exist. This information is important for effective recruitment and retention of a highly talented and diverse future cardiology workforce. To identify residents' professiona...
Published in JAMA cardiology
This survey study characterizes the distribution and trend of low-density lipoprotein cholesterol and the prevalence of screening and awareness of high cholesterol among US young adults.
Published in JAMA cardiology
Women have a lower incidence of atrial fibrillation (AF) compared with men in several studies, but it is unclear whether this sex difference is independent of sex differences in prevalent cardiovascular disease (CVD), body size, and other risk factors. To examine sex differences in AF incidence and whether AF risk factors differ by sex in a contemp...